NEUROLOGY 2004;63:959-965
© 2004 American Academy of Neurology
Special Article
Practice Parameter: Treatment of postherpetic neuralgia
An evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology*
R. M. Dubinsky, MD MPH,
H. Kabbani, MD,
Z. El-Chami, MD,
C. Boutwell, MD and
H. Ali, MD
Address correspondence and reprint requests to the American Academy of Neurology, 1080 Montreal Avenue, St. Paul, MN 55116-2325.
A systematic review of the literature on postherpetic neuralgia was performed. The authors identified studies using the National Library of Medicine’s Medline database and Cochrane Library database. The authors determined absolute reduction rate, number needed to treat (NNT), 95% CI for NNT, and number needed to harm (NNH) for successful therapies of postherpetic neuralgia. Tricyclic antidepressants, gabapentin, pregabalin, opioids, and lidocaine patch were found to be effective in reducing the pain of postherpetic neuralgia.
Received October 3, 2001.
Accepted in final form May 20, 2004.
Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the September 28 issue to find the title link for this article.
*Members of the Quality Standards Subcommittee are listed in the Appendix on page 964.
Approved by the QSS in October 2003 and by the Practice Committee in November 2003. Approved by the AAN Board of Directors in June 2004.
This article has been cited by other articles:
|
|
|
|
 
Surjya Prasad Upadhyay, Shiv Pratap Rana, S. Mishra, and S. Bhatnagar
Successful Treatment of an Intractable Postherpetic Neuralgia (PHN) Using Peripheral Nerve Field Stimulation (PNFS)
American Journal of Hospice and Palliative Medicine,
February 1, 2010;
27(1):
59 - 62.
[Abstract]
[PDF]
|
|
|
|
|
|
|
For questions on page 697
Emerg. Med. J.,
October 1, 2009;
26(10):
700 - 700.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Katz, N. B. Finnerup, and R. H. Dworkin
Clinical trial outcome in neuropathic pain: Relationship to study characteristics
Neurology,
January 22, 2008;
70(4):
263 - 272.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. M. Gajraj
Pregabalin: Its Pharmacology and Use in Pain Management
Anesth. Analg.,
December 1, 2007;
105(6):
1805 - 1815.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-Y. Cheung and M. Viney
A Unique Case of Recurrent Asystole Secondary to Paroxysmal Pain of Acute Herpetic Ophthalmicus
Anesth. Analg.,
October 1, 2007;
105(4):
1127 - 1129.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.B. Epstein, S. Elad, E. Eliav, R. Jurevic, and R. Benoliel
Orofacial Pain in Cancer: Part II--Clinical Perspectives and Management
Journal of Dental Research,
June 1, 2007;
86(6):
506 - 518.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Hauer, B. S. Wical, and L. Charnas
Gabapentin Successfully Manages Chronic Unexplained Irritability in Children With Severe Neurologic Impairment
Pediatrics,
February 1, 2007;
119(2):
e519 - e522.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. F Shneker and J. W McAuley
Pregabalin: A New Neuromodulator with Broad Therapeutic Indications
Ann. Pharmacother.,
December 1, 2005;
39(12):
2029 - 2037.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. B. Tenser and R. H. Dworkin
Herpes zoster and the prevention of postherpetic neuralgia: Beyond antiviral therapy
Neurology,
August 9, 2005;
65(3):
349 - 350.
[Full Text]
[PDF]
|
|
|
|
|
|
|
American Academy of Neurology Practice Parameter: New Drugs, and Some Old Ones, Effective for Postherpetic Neuralgia
Journal Watch Neurology,
November 29, 2004;
2004(1129):
1 - 1.
[Full Text]
|
|
|
|
